The Allspring SMID Core ETF (ASCE) is an actively managed fund primarily focused on investing in equity securities of small and medium-sized U.S. companies, generally aligning with the constituents of the Russell 2500 Index. Up to one-fifth (20%) of its total assets may be directed towards foreign companies operating in developed markets, including American Depositary Receipts (ADRs). The fund's investment strategy integrates sophisticated quantitative analysis with in-depth qualitative evaluation. This dual approach aims to identify businesses that are believed to be undervalued and possess strong prospects for future earnings growth. The quantitative component utilizes a proprietary alpha model to systematically rank securities based on valuation metrics, financial quality, and price momentum. Conversely, the qualitative assessment delves into factors such as management capabilities, product innovation, competitive positioning, and inherent business risks. ASCE maintains a concentrated portfolio, typically comprising around 50 holdings, diversified across various key sectors. A specific ethical screen is applied, as the fund avoids investing in issuers with significant operations in the alcohol, gaming, or tobacco sectors. For liquidity purposes or during periods requiring a defensive stance, the fund may also hold cash or money market instruments, which could temporarily influence its primary investment objectives.

StoneX Group Inc.

Credo Technology Group Holding Ltd

Carpenter Technology Corporation

TTM Technologies, Inc.

Corcept Therapeutics Incorporated

Blue Bird Corporation

Amneal Pharmaceuticals, Inc.

EMCOR Group, Inc.

Onto Innovation Inc.

Acadian Asset Management

Allspring SMID Core ETF

An actively managed small- and mid‑cap equity ETF that blends quantitative and fundamental research, targeting ~50 US companies with strong earnings momentum and attractive valuations

ASCE Holdings & Sector Breakdown

ASCE Holdings & Sector Breakdown